Subscribe to our newsletter here!
Receive updates on the progress of the project!
Lars-Åke Levin is a Professor of health economics at Linköping University.
21 December 2022
Teemu Niiranen MD is a Professor of internal medicine (University of Turku) and a Medical specialist (THL).
14 April 2022
We are proud to announce that AFFECT-EU will be participating to the EHRA2022 Congress in Copenhagen between the 3rd and 5th of April 2022. Our AFFECT-EU partners will be involved in several presentations throughout the duration of the event.
31 March 2022
Jesper Hastrup Svendsen is Professor of Cardiology and clinical electrophysiologist at Rigshospitalet, University of Copenhagen, Denmark. AF research areas: genetic and clinical aspects of atrial fibrillation, including medical therapy, ablation and epidemiology.
8 November 2021
This webinar is designed for general practitioners, EHRA members, ACNAP members, members of the ESC Council on Stroke and the ESC Council on Cardiology Practice, preventive cardiologists, and those wishing to update their scientific knowledge on the topic.
15 October 2021
Screening, early treatment, and personalised therapy for atrial fibrillation are on the agenda of an international meeting starting today.
12 October 2021
Despite marked progress in the management of patients with atrial fibrillation (AF), the arrhythmia remains a diagnostic and therapeutic challenge in many, in particular older individuals worldwide. It carries a significant public health burden with high mortality and morbidity, severe societal impact for affected patients and their families, and relevant cost to health care systems. This is the reason why intensive research at the basic science and clinical level is ongoing to better understand the different underlying mechanisms that are reflected by the relatively uniform electrocardiographic pattern of AF. Continue reading
1 October 2021
The September edition of the AFFECT-EU newsletter is now online.
22 September 2021
AFFECT-EU started in January 2020 with the involvement of 26 international Consortium partners. AFFECT-EU`s major goal is the development of a risk-based, accurate, and ready for implementation atrial fibrillation (AF) screening algorithm, using digital devices, for early AF detection in the community. To facilitate this, a large set of variables and biomarkers needs to be collected and harmonised, for which we set up a screening strategy and refined it through population data analysis. Continue reading
21 September 2021
Daniel Engler is the dedicated project manager for the AFFECT-EU project. He has long standing experience in the management of research projects funded by the European Union. A health scientist as well as project manager, he has been actively engaged in public health research and cardiovascular health projects.
14 September 2021
The AFFECT-EU poster titled "Atrial fibrillation screening: feasible approaches and implementation challenges across Europe" was presented at the European Society of Cardiology (ESC) 2021 Congress.
27 August 2021
The ESC Heart & Stroke conference is a three half-day online conference. This format will allow members of the diverse ESC community to join the sessions that are professionally most relevant to their daily practice.
02 June 2021
There are no screening programmes for atrial fibrillation in Europe, according to a study presented at EHRA 2021, an online scientific congress of the European Society of Cardiology (ESC).
25 April 2021
The European Heart Rhythm Association (EHRA) brings together scientists, healthcare professionals and other players involved in arrhythmia management from all around the world. The theme for this year's rdition will be “Making connections to overcome arrhythmia”.
24 March 2021
The European Society of Cardiology (ESC) today announces its participation in two large-scale EU funded projects to detect heart rhythm disorders and prevent sudden cardiac death.
20 April 2020